{"product_id":"discontinuing-antidepressant-medications","title":"Discontinuing Antidepressant Medications","description":"\u003cp\u003eOne in six people in the US are currently taking psychotropic drugs. In 80% of cases, the medication is taken for long-term use and predominantly involves new-generation antidepressants, such as SSRIs (e.g. paroxetine) and SNRIs (e.g. venlafaxine). When patients want to stop taking these drugs and\/or their physicians decide it is time for them to stop, substantial problems often can ensue. About 50% of patients experience withdrawal symptoms that do not necessarily subside after a few days or weeks and may be severe and debilitating. Physicians often do not know what to do in these situations. As a result, patients experiencing the anguish and mental pain of withdrawal syndromes are unlikely to receive appropriate medical attention. Discontinuing antidepressants is a highly technical challenge that requires specific strategies. This handbook guides clinicians through each clinical step (assessment; what the counter-indications would be for stopping or continuing; and how discontinuation can best be achieved). It provides a detailed account of the assessment and management strategies, with many case illustrations and clinical examples, drawing from the literature that is available and the extensive personal experience of the author.\u003c\/p\u003e","brand":"Giovanni A. Fava","offers":[{"title":"Default Title","offer_id":43644140781629,"sku":"9780192896643","price":83.95,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0597\/7689\/2989\/files\/9780192896643_07fe8d72-211e-4ec1-ba66-a764c7c60f4e.jpg?v=1789708534","url":"https:\/\/www.palmleaf.com.au\/products\/discontinuing-antidepressant-medications","provider":"Palmleaf","version":"1.0","type":"link"}